SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females

被引:0
|
作者
Li, Wei [1 ]
Liu, Wei [2 ]
Wang, Xiong [3 ]
Dou, Rui [1 ]
Zhu, Zunmin [1 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Inst Hematol, Henan Key Lab Stem Cell Differentiat & Modificat,P, Zhengzhou, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Publ Hlth, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China
关键词
Tuberculosis; Polymorphism; Susceptibility; Chinese females; DRUG-INDUCED HEPATOTOXICITY; RIFAMPIN CONCENTRATIONS; RISK;
D O I
10.1007/s10528-023-10392-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study aimed to evaluate the role of SLCO1B1 polymorphisms in pulmonary tuberculosis (PTB) risk among Chinese patients. This study comprised 600 PTB patients (mean age: 37.43 & PLUSMN; 12.73 years) and 600 healthy controls (mean age: 37.39 & PLUSMN; 12.57 years) from a Chinese population. The SLCO1B1 rs2306283 and rs4149056 polymorphisms were detected using TaqMan genotyping assay. Chi-square (& chi;(2)) test was applied to calculate the Hardy-Weinberg Equilibrium (HWE) among controls. Logistic regression analysis was used to examine the odds ratio (OR) and 95% confidence interval (CI). After adjustment for age and gender, the frequency of rs4149056-C was significantly higher in PTB group (P = 0.017, OR = 1.375, 95% CI 1.058-1.786); meanwhile, rs4149056 was associated with increased PTB risk in dominant model (P = 0.015, OR = 1.424, 95% CI 1.072-1.892). The frequency and genotype of rs2306283 showed no significant difference between the two groups. In stratified analysis, rs2306283-GG showed notable susceptibility to PTB (P = 0.027, OR = 1.563, 95% CI 1.051-2.323 in recessive model) in females; rs4149056-C was also significantly higher in female PTB group (P = 0.039, OR = 1.741, 95% CI 1.028-2.948). Neither of rs2306283 and rs4149056 polymorphisms was associated with PTB risk in males. A haplotype analysis showed that patients carrying at least one SLCO1B1*15 haplotype had higher PTB risk (P = 0.004, OR = 1.527, 95% CI 1.145-2.034). SLCO1B1 polymorphisms are associated with the susceptibility to pulmonary tuberculosis in Chinese females.
引用
收藏
页码:385 / 394
页数:10
相关论文
共 50 条
  • [1] SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females
    Wei Li
    Wei Liu
    Xiong Wang
    Rui Dou
    Zunmin Zhu
    Biochemical Genetics, 2024, 62 : 385 - 394
  • [2] SLCO1B1, SLCO2B1, and SLCO1B3 Polymorphisms and Susceptibility to Bladder Cancer Risk
    Hoai Thi Thu Bui
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Inatomi, Hisato
    Matsumoto, Tetsuro
    CANCER INVESTIGATION, 2014, 32 (06) : 256 - 261
  • [3] Effects of Tuberculosis, Race, and Human Gene SLCO1B1 Polymorphisms on Rifampin Concentrations
    Weiner, Marc
    Peloquin, Charles
    Burman, William
    Luo, Chi-Cheng
    Engle, Melissa
    Prihoda, Thomas J.
    Mac Kenzie, William R.
    Bliven-Sizemore, Erin
    Johnson, John L.
    Vernon, Andrew
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4192 - 4200
  • [4] SLCO1B1 polymorphisms and lopinavir plasma concentrations
    Kohlrausch, F. B.
    Estrela, R. de Cassia
    Barroso, P. F.
    Suarez-Kurtz, G.
    PHARMACOGENOMICS, 2010, 11 (07) : 917 - 918
  • [5] Polymorphisms of SLCO1B1 Gene in Sundanese Ethnic Population of Tuberculosis Patients in Indonesia
    Santoso, Prayudi
    Juliastuti, Henny
    Nataprawira, Heda Melinda
    Soeroto, Arto Yuwono
    Alisjahbana, Bachti
    Ruslami, Rovina
    Debora, Josephine
    Sribudiani, Yunia
    Maskoen, Ani Melani
    ACTA MEDICA INDONESIANA, 2022, 54 (04) : 517 - 523
  • [6] GENETIC POLYMORPHISMS IN SLCO1B1 ARE NOT ASSOCIATED WITH ALTERED VOXILAPREVIR EXPOSURE.
    Garrison, K.
    Song, Q.
    Stamm, L.
    Ling, J.
    Mathias, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S34 - S34
  • [7] Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers
    Jiake He
    Zhixia Qiu
    Ning Li
    Yang Yu
    Yang Lu
    Deen Han
    Tingting Li
    Di Zhao
    Wei Sun
    Fang Fang
    Jianheng Zheng
    Hongwei Fan
    Xijing Chen
    European Journal of Clinical Pharmacology, 2011, 67 : 701 - 707
  • [8] Effects of SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of repaglinide in healthy Chinese volunteers
    He, Jiake
    Qiu, Zhixia
    Li, Ning
    Yu, Yang
    Lu, Yang
    Han, Deen
    Li, Tingting
    Zhao, Di
    Sun, Wei
    Fang, Fang
    Zheng, Jianheng
    Fan, Hongwei
    Chen, Xijing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (07) : 701 - 707
  • [9] SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy
    Eldem, Irem
    Yavuz, Duygu
    Cumaogullari, Ozge
    Ileri, Talia
    Ince, Elif Unal
    Ertem, Mehmet
    Erdogan, Beyza Doganay
    Bindak, Recep
    Ozdag, Hilal
    Satiroglu-Tufan, N. Lale
    Uysal, L. Zumrut
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (05) : E289 - E294
  • [10] Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity
    Bins, Sander
    Lenting, Anne
    El Bouazzaoui, Samira
    van Doorn, Leni
    Oomen-de Hoop, Esther
    Eskens, Ferry A. L. M.
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    PHARMACOGENOMICS, 2016, 17 (14) : 1483 - 1490